top of page
  • Facebook
  • White Twitter Icon
  • Soundcloud
  • White Instagram Icon
  • LinkedIn
  • TikTok

Cannabis for Pain: Marijuana Legalization Reduces Opioid Demand

Updated: Apr 24, 2023

Welcome to homework assignment CPS 1.3 in the Cannabis for Pain seminar from Higher Learning LV. This seminar provides a review of recently published peer-reviewed scientific research on the topic of the potential medicinal efficacy of cannabis for pain. This assignment in particular focuses on a 2023 study about the effects of marijuana legalization on opioid usage and distribution.


When you complete this homework assignment, simply click the link at the bottom of the article to return to the master page for this seminar.

A 2023 study entitled "Recreational Cannabis and Opioid Distribution" that was published in the journal Health Economics examined the impact of cannabis legalization on "prescription opioid dispensing" by analyzing data from the U.S. Drug Enforcement Agency.


The study reported that, as of November 2022, 21 U.S. states featured adult-use (recreational) cannabis laws. It noted that "cannabis may be a substitute for prescription opioids in the treatment of chronic pain."

Want to read more?

Subscribe to curtarobbins.wixsite.com to keep reading this exclusive post.

Higher Learning LV

There are many ways to learn from us, including 👇🏽

Teaching the Commerce + Chemistry of Cannabis™

Did You Know?

The cannabis genome produces 100+ cannabinoids, 150+ terpenes, and 20 flavonoids.

These phytomolecules interact with the human endocannabinoid system (ECS) to produce wellness.

But it gets complex. Biphasic response curves, biosynthetic pathways, and acidic precursors all commingle. Subscribe to learn how. 

Copyright © 2023 Higher Learning LV. All Rights Reserved. Unauthorized reuse strictly prohibited.

bottom of page